285 related articles for article (PubMed ID: 25742996)
1. [In vitro antifungal activity of ravuconazole against isolates of dermatophytes and Candida species from patients with dermatomycoses].
Yamaguchi H; Ikeda F; Iyoda T; Suzuki M; Mikawa T
Med Mycol J; 2014; 55(4):J157-63. PubMed ID: 25742996
[TBL] [Abstract][Full Text] [Related]
2. In Vitro Ravuconazole Susceptibility of Anthropophilic Dermatophyte Strains Isolated from Japanese Patients.
Kano R; Hiruma J; Yokota M; Noguchi H; Hase M; Kamata H; Harada K; Hiruma M
Jpn J Infect Dis; 2020 May; 73(3):250-252. PubMed ID: 31875604
[TBL] [Abstract][Full Text] [Related]
3. In vitro activities of posaconazole, ravuconazole, terbinafine, itraconazole and fluconazole against dermatophyte, yeast and non-dermatophyte species.
Gupta AK; Kohli Y; Batra R
Med Mycol; 2005 Mar; 43(2):179-85. PubMed ID: 15832561
[TBL] [Abstract][Full Text] [Related]
4. In vitro susceptibility of dermatomycoses agents to six antifungal drugs and evaluation by fractional inhibitory concentration index of combined effects of amorolfine and itraconazole in dermatophytes.
Tamura T; Asahara M; Yamamoto M; Yamaura M; Matsumura M; Goto K; Rezaei-Matehkolaei A; Mirhendi H; Makimura M; Makimura K
Microbiol Immunol; 2014 Jan; 58(1):1-8. PubMed ID: 24215461
[TBL] [Abstract][Full Text] [Related]
5. Comparison of in vitro antifungal activities of efinaconazole and currently available antifungal agents against a variety of pathogenic fungi associated with onychomycosis.
Jo Siu WJ; Tatsumi Y; Senda H; Pillai R; Nakamura T; Sone D; Fothergill A
Antimicrob Agents Chemother; 2013 Apr; 57(4):1610-6. PubMed ID: 23318803
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis.
Bueno JG; Martinez C; Zapata B; Sanclemente G; Gallego M; Mesa AC
Clin Exp Dermatol; 2010 Aug; 35(6):658-63. PubMed ID: 19874354
[TBL] [Abstract][Full Text] [Related]
7. Determination of minimum inhibitory concentrations of itraconazole, terbinafine and ketoconazole against dermatophyte species by broth microdilution method.
Bhatia VK; Sharma PC
Indian J Med Microbiol; 2015; 33(4):533-7. PubMed ID: 26470960
[TBL] [Abstract][Full Text] [Related]
8. Antifungal susceptibilities of dermatophytic agents isolated from clinical specimens.
Cetinkaya Z; Kiraz N; Karaca S; Kulac M; Ciftci IH; Aktepe OC; Altindis M; Kiyildi N; Piyade M
Eur J Dermatol; 2005; 15(4):258-61. PubMed ID: 16048753
[TBL] [Abstract][Full Text] [Related]
9. Tacrolimus, not triamcinolone acetonide, interacts synergistically with itraconazole, terbinafine, bifonazole, and amorolfine against clinical dermatophyte isolates.
Zhang J; Tan J; Yang L; He Y
J Mycol Med; 2018 Dec; 28(4):612-616. PubMed ID: 30337054
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of the protegrin IB-367 alone and in combination compared with conventional antifungal agents against dermatophytes.
Simonetti O; Silvestri C; Arzeni D; Cirioni O; Kamysz W; Conte I; Staffolani S; Orsetti E; Morciano A; Castelli P; Scalise A; Kamysz E; Offidani AM; Giacometti A; Barchiesi F
Mycoses; 2014 Apr; 57(4):233-9. PubMed ID: 26058322
[TBL] [Abstract][Full Text] [Related]
11. In vitro Azole Susceptibility Testing of Japanese Isolates of Itraconazole-Resistant Dermatophytes.
Nojo H; Hiruma J; Noguchi H; Hiruma M; Harada K; Makimura K; Kano R
Med Mycol J; 2023; 64(4):103-105. PubMed ID: 38030274
[TBL] [Abstract][Full Text] [Related]
12. In vitro activities of antifungal drugs against dermatophytes isolated in Tokat, Turkey.
Yenişehirli G; Tunçoğlu E; Yenişehirli A; Bulut Y
Int J Dermatol; 2013 Dec; 52(12):1557-60. PubMed ID: 24134487
[TBL] [Abstract][Full Text] [Related]
13. Combinatorial effect of fluconazole, itraconazole, and terbinafine with different culture extracts of Candida parapsilosis and Trichophyton spp. against Trichophyton rubrum.
Lemes TH; Nascentes JAS; Regasini LO; Siqueira JPZ; Maschio-Lima T; Pattini VC; Ribeiro MD; de Almeida BG; de Almeida MTG
Int Microbiol; 2024 Jun; 27(3):899-905. PubMed ID: 37875749
[TBL] [Abstract][Full Text] [Related]
14. Effect of Lamisil and azole antifungals in experimental nail infection.
Richardson MD
Dermatology; 1997; 194 Suppl 1():27-31. PubMed ID: 9154398
[TBL] [Abstract][Full Text] [Related]
15. Fungicidal versus fungistatic activity of terbinafine and itraconazole: an in vitro comparison.
Hazen KC
J Am Acad Dermatol; 1998 May; 38(5 Pt 3):S37-41. PubMed ID: 9594935
[TBL] [Abstract][Full Text] [Related]
16.
Rezaei-Matehkolaei A; Khodavaisy S; Alshahni MM; Tamura T; Satoh K; Abastabar M; Shokoohi GR; Ahmadi B; Kord M; Taghipour S; Makimura K; Badali H
Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29530856
[TBL] [Abstract][Full Text] [Related]
17. In vitro evaluation of antifungal susceptibility and keratinase, elastase, lipase and DNase activities of different dermatophyte species isolated from clinical specimens in Iran.
Sharifzadeh A; Shokri H; Khosravi AR
Mycoses; 2016 Nov; 59(11):710-719. PubMed ID: 27291045
[TBL] [Abstract][Full Text] [Related]
18. Comparison of disk diffusion method and broth microdilution method for antifungal susceptibility testing of dermatophytes.
Esteban A; Abarca ML; Cabañes FJ
Med Mycol; 2005 Feb; 43(1):61-6. PubMed ID: 15712608
[TBL] [Abstract][Full Text] [Related]
19. Comparison of in vitro activities of newer triazoles and classic antifungal agents against dermatophyte species isolated from Iranian University Hospitals: a multi-central study.
Badiee P; Shokohi T; Hashemi J; Mohammadi R; Najafzadeh MJ; Amin Shahidi M; Ghasemi F; Jafarian H
Ann Clin Microbiol Antimicrob; 2023 Feb; 22(1):15. PubMed ID: 36805670
[TBL] [Abstract][Full Text] [Related]
20. In Vitro activity of ravuconazole against Candida auris and vaginal candida isolates.
Dong J; Liang G; Zheng H; Kan S; Song N; Zhang M; Liu W
Mycoses; 2021 Jun; 64(6):651-655. PubMed ID: 33609301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
